# Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Controlling Asthma in American Cities Project Phase II-Intervention Implementation, Program Announcement #03030
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:
*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Controlling Asthma in American Cities Project Phase II-Intervention Implementation, Program Announcement #03030.
*Times and Dates:*
8:30 a.m.-9:15 a.m., July 23, 2003. (Open.)
9:15 a.m.-4:30 p.m., July 23, 2003. (Closed.)
8:30 a.m.-4:30 p.m., July 24, 2003. (Closed.)
*Place:* Sheraton Colony Square, 188 14th Street, Atlanta, GA 30361, Telephone 404-892-6000.
*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement #03030.
*Contact Person for More Information:* Drue Barrett, Ph.D., Deputy Associate Director for Science, National Center for Environmental Health, CDC, 4770 Buford Highway, MS F29, Atlanta, GA 30341, Telephone 770-488-7653.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: June 25, 2003.
John Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.